Premium
Are the real‐life outcomes of using aflibercept in diabetic macular oedema comparable to the landmark studies?
Author(s) -
Higham Aisling K.,
Tahir Muhammad I.,
Gala Kavita,
Verroiopoulos Georgios
Publication year - 2019
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13945
Subject(s) - aflibercept , medicine , visual acuity , ophthalmology , nice , ranibizumab , retrospective cohort study , cohort , diabetic retinopathy , optometry , surgery , diabetes mellitus , bevacizumab , chemotherapy , computer science , programming language , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom